Treatment Resources

Displaying 433 - 444 of 538

This 2013 SAMHSA report describes the core elements of screening, brief intervention, brief treatment, and referral to treatment (SBIRT) programs and provides general administrative and managerial information relevant to implementing SBIRT services, including: SBIRT effectiveness; implementation models; challenges and barriers to implementation; issues of cost and sustainability; and real-life program anecdotes and case studies.

Response Approach
  • Early Intervention
Stakeholders
  • Addiction Treatment Providers
  • Community Health Officials
  • Health Insurers
  • Hospitals
  • Medical
  • Policymakers

This is a report from the National Academy for State Health Policy (NASHP) that explores innovative approaches Louisiana, New York, and West Virginia have taken to address co-occurring HIV and Hepatitis C (HCV) infections and substance use disorder (SUD) – providing both rural and urban perspectives – and highlights their resourceful use of funding streams, leveraging of data, and advancing community readiness.

Response Approach
  • Comprehensive services
  • Syringe service program / Needle exchange
Stakeholders
  • Addiction Treatment Providers
  • Community Coalitions
  • Community Health Officials
  • Hospitals
  • Medical
  • Policymakers

This is an academic paper that documents the currently available opioid-related smartphone apps and reviews past and existing technology solutions that address opioid use disorder (OUD), including educational apps for prescribers, wearable sensors, and GPS locator apps. 

Response Approach
  • Cautious Opioid Prescribing
  • Educational
  • Overdose prevention
Stakeholders
  • Addiction Treatment Providers
  • Health Insurers
  • Hospitals
  • Medical
Peer-reviewed Article

This paper analyzes the current state of telehealth services at the federal and state levels, as well as the benefits and limitations of telehealth technology use. It also offers public policy recommendations to improve telehealth services in the United States. 

Stakeholders
  • Addiction Treatment Providers
  • Community Health Officials
  • Medical

This is an academic paper that describes the importance of using telemedicine to treat substance use disorders (SUD) during the COVID-19 pandemic. It discusses policy changes that have reduced barriers and provides recommendations on how to sustain implementation of telehealth into SUD treatment after the pandemic. 

Response Approach
  • COVID / Coronavirus related
  • Medications for Opioid Use Disorder
Stakeholders
  • Addiction Treatment Providers
  • Medical
  • Policymakers

This is a report from SAMHSA that reviews the literature on the effectiveness of telehealth modalities for the treatment of severe mental illness (SMI) and substance use disorder (SUD), distills the research into recommendations for practice, and provides examples of how practitioners use these practices in their programs.

Response Approach
  • Medications for Opioid Use Disorder
Stakeholders
  • Addiction Treatment Providers
  • Health Insurers
  • Hospitals
  • Medical
  • Policymakers

This is an academic paper that presents promising findings from the HEROES program in Texas that reported an overall increase in patient engagement over time after rapidly enacted virtual care with telehealth for peer coaching, counseling, groups, and provider visits in response to the coronavirus pandemic. 

Response Approach
  • COVID / Coronavirus related
  • Medications for Opioid Use Disorder
  • Post-overdose response
Stakeholders
  • Addiction Treatment Providers
  • Community Health Officials
  • Medical
  • Policymakers

This is a CADTH Rapid Response Report that gives a critical appraisal on providing medications for opioid use disorder (MOUD) via telemedicine. The report summarizes the evidence for telehealth-delivered MOUD and provides evidence-based guidelines, a cost-effective analysis, and guidance on initiation of MOUD at home. 

Response Approach
  • Medications for Opioid Use Disorder
Stakeholders
  • Addiction Treatment Providers
  • Medical

This is a brief report from the US Dept. of Health and Human Services that provides clinical scenario examples that are compliant with current DEA policies around using telehealth to deliver medications for opioid use disorder (MOUD). 

Response Approach
  • Medications for Opioid Use Disorder
Stakeholders
  • Addiction Treatment Providers
  • Hospitals
  • Medical
  • Policymakers

This is an academic paper that provides commentary on leveraging telehealth to increase the capacity of medications for opioid use disorder (OUD). Current evidence, existing state laws, barriers, and policy recommendations are discussed. 

Response Approach
  • Medications for Opioid Use Disorder
Stakeholders
  • Addiction Treatment Providers
  • Community Coalitions
  • Community Health Officials
  • Hospitals
  • Medical
  • Policymakers
Peer-reviewed Article

This is an academic paper that provides commentary on the importance of telemedicine as a tool to address the opioid crisis. Applying telehealth to delivering medications for opioid use disorder (MOUD) has the potential to overcome barriers that keep people with opioid use disorder (OUD) from seeking treatment. 

Response Approach
  • Medications for Opioid Use Disorder
Stakeholders
  • Addiction Treatment Providers
  • Community Health Officials
  • Health Insurers
  • Hospitals
  • Medical
  • Policymakers
Peer-reviewed Article

This is a report from the Police Executive Research Forum, which convened public safety and public health experts to provide recommendations as standards of care for police departments in addressing the opioid crisis. Additionally, successfully implemented models are highlighted in this document. 

Response Approach
  • Diversion
  • Educational
  • Overdose prevention
Stakeholders
  • Criminal Justice
  • First Responders
  • Law Enforcement
  • Policymakers